New Providence Acquisition Corp. III Class A (NPAC)

NASDAQ:NPAC

NPAC

New Providence Acquisition Corp. III Class A

RESEARCH TOOLSreports

Compare New Providence Acquisition Corp. III Class A (NPAC) vs. Competitors

0 Followers

Comparison Results

NPAC

New Providence Acquisition Corp. III Class A

$10.29

$395.04M

―

-1.06%

―

Bayview Acquisition Corp Class A

$11.92

$32.72M

28.28

9.53%

―

Roma Green Finance Limited

$4.74

$282.34M

-14.60

404.79%

―

FibroBiologics, Inc.

$1.40

$4.92M

-0.54

-91.41%

2 Buy

1 Hold

0 Sell

Moderate Buy

Alto Neuroscience, Inc.

$21.71

$693.54M

-8.12

969.46%

9 Buy

1 Hold

0 Sell

Strong Buy

Telomir Pharmaceuticals, Inc.

$1.35

$45.73M

-4.04

-48.45%

1 Buy

0 Hold

0 Sell

Moderate Buy

xxxxxxxxxxxxx

NPAC vs TELO

xxxxxxxxxxxxx

Performance Comparison

NPAC

New Providence Acquisition Corp. III Class A

10.29

-0.06

-0.58%

BAYA

Bayview Acquisition Corp Class A

11.95

1.03

9.43%

ROMA

Roma Green Finance Limited

4.74

3.75

378.79%

FBLG

FibroBiologics, Inc.

1.40

-14.86

-91.39%

ANRO

Alto Neuroscience, Inc.

21.71

19.66

959.02%

TELO

Telomir Pharmaceuticals, Inc.

1.33

-1.32

-49.81%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >